Related references
Note: Only part of the references are listed.PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades
Yongrong Yan et al.
Aging-US (2021)
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Peter Kalev et al.
CANCER CELL (2021)
Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
Harshita Shailesh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Circ-PRMT5 promotes breast cancer by the miR-509-3p/TCF7L2 axis activating the PI3K/AKT pathway
Di Wu et al.
JOURNAL OF GENE MEDICINE (2021)
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Kamakoti P. Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma
Yoshihiro Otani et al.
NEURO-ONCOLOGY (2021)
PRMT5 inhibition disrupts splicing and stemness in glioblastoma
Patty Sachamitr et al.
NATURE COMMUNICATIONS (2021)
Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition
Jie Gao et al.
CELL DEATH AND DIFFERENTIATION (2021)
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan Quiroz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype
Geraldine Ezeka et al.
MOLECULAR CARCINOGENESIS (2021)
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Qin Wu et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez et al.
NATURE COMMUNICATIONS (2021)
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth
Wen-juan Li et al.
NATURE COMMUNICATIONS (2021)
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
Liu Liu et al.
CANCER SCIENCE (2021)
PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells
Khuloud Bajbouj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
Shasha Yin et al.
NATURE COMMUNICATIONS (2021)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Gerhard Jung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
Antja-Voy Hartley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PRMT5 Promotes Aerobic Glycolysis and Invasion of Breast Cancer Cells by Regulating the LXRα/NF-κBp65 Pathway
Xiao Han et al.
ONCOTARGETS AND THERAPY (2020)
OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation
Mingyi Yang et al.
CELL REPORTS (2020)
CML - Not only BCR-ABL1 matters
Jenny Rinke et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
Yudao Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity
Hyungsoo Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
Rachel L. Palte et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer
Antja-Voy Hartley et al.
SCIENTIFIC REPORTS (2020)
Protein Arginine Methyltransferase PRMT5 Regulates Fatty Acid Metabolism and Lipid Droplet Biogenesis in White Adipose Tissues
Zhihao Jia et al.
ADVANCED SCIENCE (2020)
The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties
Na Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The role of histone methylation in the development of digestive cancers: a potential direction for cancer management
Yuan Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4
Qianqian Wang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2019)
Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling
Jihyun Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
PRMT1 loss sensitizes cells to PRMT5 inhibition
Guozhen Gao et al.
NUCLEIC ACIDS RESEARCH (2019)
NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression
Christina Demetriadou et al.
CELL DEATH & DISEASE (2019)
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
Hong Lin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Role of protein arginine methyltransferase 5 in human cancers
Wendi Xiao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw et al.
CANCER CELL (2019)
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
Shatha AbuHammad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cancer Progress and Priorities: Lung Cancer
Matthew B. Schabath et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury
Changhui Diao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis
Lixue Cao et al.
NATURE COMMUNICATIONS (2019)
A patent review of arginine methyltransferase inhibitors (2010-2018)
Xiao Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498
Yuan Wang et al.
GENE (2019)
PRMT5 is essential for B cell development and germinal center dynamics
Ludivine C. Litzler et al.
NATURE COMMUNICATIONS (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth
Hironari Tamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma
A. Gulla et al.
LEUKEMIA (2018)
PRMT5 as a druggable target for glioblastoma therapy
Yeshavanth Kumar Banasavadi-Siddegowda et al.
NEURO-ONCOLOGY (2018)
Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells
Dariusz Zakrzewicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling
Pengyu Jing et al.
CANCER LETTERS (2018)
Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery
Yuanxiang Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes
Ishita Rehman et al.
NUCLEIC ACIDS RESEARCH (2018)
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q. Bonday et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
Qianqian Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer models
Tongfei Wu et al.
CANCER RESEARCH (2018)
Classical molecular dynamics and metadynamics simulations decipher the mechanism of CBP30 selectively inhibiting CBP/p300 bromodomains
Qianqian Wang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
The biological significance of histone modifiers in multiple myeloma: clinical applications
Hiroto Ohguchi et al.
BLOOD CANCER JOURNAL (2018)
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Pierre-Jacques Hamard et al.
CELL REPORTS (2018)
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition
Xin Chen et al.
CLINICAL CANCER RESEARCH (2018)
Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations
Sen Ji et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation
Nicola Amodio et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
Y. K. Banasavadi-Siddegowda et al.
ONCOGENE (2017)
Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization
Ruifeng Mao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Nitric Oxide Regulates Protein Methylation during Stress Responses in Plants
Jiliang Hu et al.
MOLECULAR CELL (2017)
Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening
Yan Ye et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer
Ying Wu et al.
TUMOR BIOLOGY (2017)
Colorectal cancer screening: An updated review of the available options
Iyad A. Issa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion
Tingxiong Fu et al.
ONCOTARGET (2017)
Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations
Qianqian Wang et al.
SCIENTIFIC REPORTS (2017)
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression
Kelly Chiang et al.
CELL REPORTS (2017)
Recent progress in developing selective inhibitors of protein methyltransferases
H. Umit Kaniskan et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2
Yonghui Dong et al.
CELLULAR SIGNALLING (2017)
The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation
S. S. Tarighat et al.
LEUKEMIA (2016)
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
Yanli Jin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Nicole Stopa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
Fan Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin
Baolai Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Genomic alterations in lung adenocarcinoma
Siddhartha Devarakonda et al.
LANCET ONCOLOGY (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
High nuclear expression of protein arginine methyltransferase-5 is a potentially useful marker to estimate submucosal invasion in endoscopically resected early colorectal carcinoma
Min Gyoung Pak et al.
PATHOLOGY INTERNATIONAL (2015)
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3
Baolai Zhang et al.
ONCOTARGET (2015)
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Fengting Yan et al.
CANCER RESEARCH (2014)
Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
Reem Ibrahim et al.
HUMAN PATHOLOGY (2014)
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
Xiaosi Han et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
Konstantin Shilo et al.
DIAGNOSTIC PATHOLOGY (2013)
The role of WDR5 in silencing human fetal globin gene expression
Zhen Xu et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Crystal structure of the human PRMT5:MEP50 complex
Stephen Antonysamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
John S. Sack et al.
BIOCHEMICAL JOURNAL (2011)
JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
Fan Liu et al.
CANCER CELL (2011)
Versatility of PRMT5-induced methylation in growth control and development
Vrajesh Karkhanis et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase
Priya Aggarwal et al.
CANCER CELL (2010)
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)
Martin Allan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Sharmistha Pal et al.
EMBO JOURNAL (2007)
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Chi-Hwa Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Share Paper
